Trafalgar International (GCAN) Enterprise Value (QoQ) (2017 - 2026)
Trafalgar International (GCAN) Enterprise Value (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.56% |
| Dec 31, 2025 | 96.18% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 42.20% |
| Mar 31, 2025 | 19.44% |
| Dec 31, 2024 | 7.89% |
| Sep 30, 2024 | 22.45% |
| Jun 30, 2024 | 37.90% |
| Mar 31, 2024 | 22.50% |
| Dec 31, 2021 | 17.28% |
| Sep 30, 2021 | 13.72% |
| Jun 30, 2021 | -67.00% |
| Mar 31, 2021 | -180.40% |
| Dec 31, 2020 | 36.77% |
| Sep 30, 2020 | 21.83% |
| Jun 30, 2020 | 22.62% |
| Mar 31, 2020 | -1,097.45% |
| Dec 31, 2019 | 46.21% |
| Sep 30, 2019 | 43.42% |
| Jun 30, 2019 | 50.87% |